Our observations underscore the importance of anticipating a broad phenotypic spectrum for such potential molecular alterations in ATP5F1A/ATP5F1B‐related conditions, ranging from isolated or complex dystonia to HSP and CP. This evidence concerns the gene ATP5F1B and hereditary spastic paraplegia.